Actively Recruiting
Comparing Virtual Reality Sedation to Neuroleptanalgesia in Outpatient Surgery for Superficial Venous Insufficiency
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2025-12-03
400
Participants Needed
2
Research Sites
4 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the use of virtual reality as a method to reduce pain during the endovenous thermal treatment of superficial varicose veins. The study aims to see if virtual reality sedation can delay the need for neuroleptanalgesia when combined with local anesthesia by tumescence. This is a prospective, randomized, open-label study involving 200 patients, focused on comparing pain intensity during surgery. Participants are divided into two groups one group receives local anesthesia by tumescence plus the usual neuroleptanalgesia treatment, while the other group receives local anesthesia with virtual reality software for sedation. The study tests if virtual reality sedation is not inferior to traditional neuroleptanalgesia by measuring maximum intraoperative pain. The entire participation lasts up to 2 days. During the study, pain is assessed immediately after surgery using a numerical rating scale. Researchers will also evaluate pre- and post-operative anxiety, overall patient satisfaction, surgery duration, ICU and hospital stay length, and time to resume normal activities. Safety and treatment details are monitored throughout, with the primary outcome focused on pain intensity on the first day.
CONDITIONS
Brief Title
Minimally Invasive Superficial Venous Insufficiency Surgery and Digital Sedation
Research Team
L
Lauranne MATRAY, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here